Emergent BioSolutions stepped up its response to the U.S. opioid crisis in 2018 with its buyout of Adapt Pharma and its overdose-reversing naloxone ...
Emergent's next-gen nasal spray device snares shelf life extension for opioid overdose drug Narcan
- Written by: Drug News Feed
- Category: Drug News
- Hits: 492